瘤衍生的细胞外囊泡对新陈代谢的生物学功能
Xiaoyu Fu1,2, Junlong Song1, Wei Yan3
1Department of Breast and Thyroid Surgery, Renmin Hospital of Wuhan University, Wuhan, 430060, Hubei, China.
Cell communication and signaling : CCS
|June 22, 2023
概括
瘤衍生的细胞外囊泡 (TDE) 影响瘤微环境和宿主代谢. 作为早期癌症诊断的生物标志物和新型癌症治疗的目标,TDE具有潜力.
科学领域:
- 细胞生物学 细胞生物学
- 在瘤学瘤学.
- 生物化学 生化学
背景情况:
- 细胞外囊泡 (EVs),包括外体,介导细胞间通信.
- 与正常的EV相比,瘤衍生的EV (TDE) 呈现出改变的组成和数量.
- TDEs影响瘤微环境和宿主代谢,影响葡萄糖,脂质和氨基酸调节.
研究的目的:
- 审查TDE对瘤微环境的影响.
- 总结TDE对全身新陈代谢的影响.
- 突出TDE在癌症诊断和治疗中的临床潜力.
主要方法:
- 对研究TDE的文献综述.
- 分析TDE在调节代谢途径中的作用.
- 评估TDE作为生物标志物和治疗目标.
主要成果:
- 通过改变微环境,TDE促进瘤的发展.
- TDEs显著影响宿主葡萄糖,脂质和氨基酸代谢.
- TDEs可以调节宿主免疫系统.
结论:
- 在塑造瘤微环境和系统代谢方面,TDE至关重要.
- 作为癌症的早期诊断生物标志物,TDE具有前途.
- 准TDE及其生物活性货物是癌症治疗的可行策略.
更多相关视频
相关概念视频
Overview of Exosomes
2.8K
Exosomes are stable, lipid bilayer-enclosed vesicles capable of crossing biological barriers. They can carry a wide range of molecules required for intercellular communication. Once exosomes are released from the cell where they originated, they enter a recipient cell through various pathways such as fusion, receptor-mediated endocytosis, macropinocytosis, and phagocytosis.
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
2.8K
The Tumor Microenvironment
6.7K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.7K
Metastasis
5.6K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.6K
Adaptive Mechanisms in Cancer Cells
5.8K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.8K
Intralumenal Vesicles and Multivesicular Bodies
3.6K
Intraluminal vesicles (ILVs) are small vesicles 50-80 nm in diameter formed during the maturation of early endosomes. A specialized endosome containing numerous ILVs is called a multivesicular body (MVB). ILVs contain internalized molecules such as antigens, nucleic acids, proteins, and metabolites. Some of these molecules are released from the MVBs inside exosomes and are transported to other cells. Other MVBs contain molecules that are retained in the ILVs and are later degraded within the...
3.6K
Cancer Stem Cells and Tumor Maintenance
5.0K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
5.0K


